The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
about
Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinomaInteraction between circulating cancer cells and platelets: clinical implicationPlatelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation.Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregationExpression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis.Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragmentPlatelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis.Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growthPKA and CDK5 can phosphorylate specific serines on the intracellular domain of podoplanin (PDPN) to inhibit cell motilityPDGF upregulates CLEC-2 to induce T regulatory cellsIdentification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisBiology in prevention and treatment of brain metastases.Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis.Human Cancer and Platelet Interaction, a Potential Therapeutic Target.Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer.
P2860
Q26743903-2606480D-8F1B-4453-A3FC-850B92FA011BQ26778920-D40EE259-6F90-45E5-8A29-8E31BF4F5EEEQ31133789-5682C819-A982-4B40-8AC4-015679EFDB63Q33607564-A139EE6D-5D4B-4AF6-A01F-4DD634FEC243Q33826371-C1C174CC-7681-4BE5-8250-52979534F07DQ34522088-6CFBBA51-2C2D-4204-B3DD-D8065614CCEBQ34982597-6B697277-3B52-4721-87F7-D86FAE0A48D2Q35051665-E2588DA3-E657-4248-B7C6-0DCEC25A524BQ35832431-35FEAE25-BD4D-4342-9B04-4E153432FDE9Q36015517-98848138-CF72-4AB7-B3CF-4F6DA2D95F81Q36557110-31D8EB43-47FA-4B36-89EE-69D79D559907Q36618989-D1ACC66D-9AAC-4E43-854A-F0455060F271Q38156192-F7D90E0E-6A97-4357-B0B5-556B719AD169Q46214152-C9B4BC29-228E-464F-AE2C-9364F9CADD6FQ50143864-DA30273B-48E5-46F2-8EB6-09EAB53BC9F1Q52717949-8761B409-EA17-4930-875E-A5D574CB8182Q54964718-04B81583-9AF7-4A36-BCEE-DC3FC33690A5
P2860
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
@en
type
label
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
@en
prefLabel
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
@en
P2860
P356
P1476
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.
@en
P2093
Naoya Fujita
Satoshi Takagi
P2860
P304
P356
10.1093/JB/MVS108
P577
2012-09-19T00:00:00Z